# Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures

Study · id `cardio:ct-nct02954029` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02954029](<https://clinicaltrials.gov/study/NCT02954029>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02954029

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 315 participants.

## Technical summary

Registry record NCT02954029. Randomized; single masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 315 participants (planned count; ClinicalTrials.gov record NCT02954029, source copy `cardio:ctgov-nct02954029-2016-11-03`, retrieved 2026-10-26)
- Start date: 2016-04 (registry gives no type) (ClinicalTrials.gov record NCT02954029, source copy `cardio:ctgov-nct02954029-2016-11-03`, retrieved 2026-10-26)
- Primary completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT02954029, source copy `cardio:ctgov-nct02954029-2016-11-03`, retrieved 2026-10-26)
- Completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT02954029, source copy `cardio:ctgov-nct02954029-2016-11-03`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02954029, source copy `cardio:ctgov-nct02954029-2016-11-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02954029-2016-11-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures
- Condition: Coronary Artery Disease
- Condition: Puncture
- Intervention (Device): ezClot (hemostasis pad)
- Intervention (Device): BloodSTOP ix pad
- Intervention (Device): Rotary compression device
- Lead sponsor: Seoul National University Bundang Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Seoul National University Bundang Hospital (`cardio:org-seoul-national-university-bundang-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hemostasis pad combined with compression device after transradial coronary procedures: A randomized controlled trial (`cardio:pubmed-28742134`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 65d60226e464a243d02df85b7ceb909b5e2278d8666381c91befe7a2963e1f65
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
